REMEGEN

Forecast & Rating15 analysts currently cover REMEGEN, with about 73.3% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$116.30, about 40.5% upside from the current price of HK$82.75. Price targets range from HK$76.53 to HK$143.65 — a wide spread, showing clear disagreement over just how much REMEGEN can rise. Historically, about 61.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study REMEGEN closely still see room for the stock to rise. Data as of Jul 25, 2026; for reference only and not investment advice.